Results for tag: "Topoisomerase Inhibitor"

Topoisomerase Inhibitor antibiotics are a class of drugs used to treat bacterial infections. They work by inhibiting the activity of topoisomerase enzymes, which are essential for bacterial replication. This prevents the bacteria from replicating and spreading, leading to their death. Topoisomerase Inhibitor antibiotics are used to treat a wide range of bacterial infections, including those caused by Gram-positive and Gram-negative bacteria. They are also used to treat infections caused by multi-drug resistant bacteria. The Topoisomerase Inhibitor market is a rapidly growing segment of the global antibiotics market. This is due to the increasing prevalence of multi-drug resistant bacteria, which require the use of more powerful antibiotics. The market is expected to continue to grow in the coming years, as the need for more effective antibiotics increases. Some of the major companies in the Topoisomerase Inhibitor market include Merck & Co., Pfizer, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more